Cover Image

Retrospective comparative study on artificial reproductive technology outcomes in women undergoing in vitro fertilization with recombinant gonadotropins

Introduction. Currently, various hormonal preparations are used in assisted reproductive technology (ART) programs which allow to profoundly improve protocols for stimulating superovulation.Aim: to comparatively analyze effectiveness of recombinant follicle-stimulating hormone preparations in in vit...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. A. Kurtser (Author), G. V. Kasyanova (Author), M. M. Ovchinnikova (Author), D. T. Khetagurova (Author)
Format:	Book
Published:	IRBIS LLC, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Urinary versus recombinant gonadotropins for ovarian stimulation in women undergoing treatment with assisted reproductive technology
by: Ameet Patki, et al.
Published: (2018)

The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
by: Mhd Jawad Al Rahwanji, et al.
Published: (2022)

Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison
by: Zhisong Ji, et al.
Published: (2020)

Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization
by: Cong Lin, et al.
Published: (2010)

The effect of follicle-stimulating hormone administration on the day of human chorionic gonadotropin trigger on assisted reproductive technique outcomes in patients undergoing In vitro fertilization-embryo transfer: A retrospective cohort study
by: Chithira Pulimoottil Vignarajan, et al.
Published: (2020)

Reproductive outcomes in women with unicornuate uterus undergoing in vitro fertilization: a nested case-control retrospective study
by: Yanrong Chen, et al.
Published: (2018)

Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT
by: Maryam Eftekhar, et al.
Published: (2020)

Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study
by: Liang Y, et al.
Published: (2024)

Gonadotropins in assisted reproductive technology programs: A review
by: Sabina Ya. Ostrina, et al.
Published: (2024)

Fixed versus flexible gonadotropin releasing hormone antagonist protocol in women with polycystic ovary syndrome undergoing in vitro fertilization: An RCT
by: Hanieh Fatehi, et al.
Published: (2024)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
by: Rohit Gutgutia, et al.
Published: (2014)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
by: F. S. Mennini, et al.
Published: (2018)

Does double dose of recombinant human chorionic gonadotropin for final follicular maturation in in vitro fertilization cycles improve oocyte quality: A prospective randomized study
by: Neeta Singh, et al.
Published: (2019)

Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature
by: Neeta Singh, et al.
Published: (2014)

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
by: Wex J, et al.
Published: (2013)

Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection
by: Emre Goksan Pabuccu, et al.
Published: (2015)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
by: Binarwan Halim, et al.
Published: (2022)

Induction of Gonadotropins for Reproductive Control
by: Elza Ibrahim Auerkari
Published: (2015)

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs
by: E M Savelyeva, et al.
Published: (2016)

Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2020)

ASSISTED REPRODUCTIVE TECHNOLOGIES FOR FERTILITY PRESERVATION OF CANCER PATIENTS
by: M. V. Kiseleva, et al.
Published: (2014)

Fertility preservation in an oncology patient who presented with positive human chorionic gonadotropin
by: Olivia Carpinello, M.D, et al.
Published: (2020)

Corifollitropin Alfa Compared to Daily Recombinant FSH in in Vitro Fertilization Programmes: A Meta-Analysis of Randomized-Controlled Trials
by: Maria Cristina Budani, et al.
Published: (2023)

Increased Progesterone/Estradiol Ratio on the Day of hCG Administration Adversely Affects Success of In Vitro Fertilization-Embryo Transfer in Patients Stimulated with Gonadotropin-releasing Hormone Agonist and Recombinant Follicle-stimulating Hormone
by: Yu-Che Ou, et al.
Published: (2008)

Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization
by: Somkuti Stephen, et al.
Published: (2005)

Comparative study of serum progesterone levels at the time of human chorionic gonadotropin trigger and ovum pickup in predicting outcome in fresh in vitro fertilization cycles
by: Srinivas Sangisapu, et al.
Published: (2019)

Comparative Study of Serum Progesterone Levels at the Time of Human Chorionic Gonadotropin Trigger and Ovum Pickup in Predicting Outcome in Fresh in vitro Fertilization Cycles
Published: (2019)

Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing fertilization
by: Hwajeong Lee, et al.
Published: (2018)

Satisfaction and usability of the recombinant chorionic gonadotropin prefilled pen: a survey in Italy
by: Chiara Dallagiovanna, et al.
Published: (2022)

Effect of Low-dose Human Chorionic Gonadotropin on the Prevention of Ovarian Hyperstimulation Syndrome and in Vitro Fertilization Outcome
by: Mahsomeh Hajishafiha, et al.
Published: (2018)

First‐in‐human trial assessing the pharmacokinetic‐pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age
by: Lars‐Erik Broksø Kyhl, et al.
Published: (2021)

Factors associated with disparate outcomes among Black women undergoing in vitro fertilization
by: Luwam Ghidei, M.D, et al.
Published: (2022)

Simultaneous laparoscopy for endometriotic women undergoing in vitro fertilization
by: Man-Ling Chen, et al.
Published: (2012)

Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
by: Leizhen Xia, et al.
Published: (2024)

Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology
by: Deepika Pratap, et al.
Published: (2014)

Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
by: Zhanhui Ou, et al.
Published: (2023)

Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
by: Beril Gurlek, et al.
Published: (2020)

Repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome undergoing In Vitro fertilization cycles provides a better cycle outcome - a proof-of-concept study
by: Krishna Deepika, et al.
Published: (2017)

Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT
by: Robabeh Taheripanah, et al.
Published: (2017)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
by: M. Kirshenbaum, et al.
Published: (2021)